Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Performances Evaluation of New FibroScan Probes Dedicated to Morbidly Obese Patients - NEO Study

NCT03872024 is registered in ClinicalTrials.gov with Echosens as lead sponsor.

NCT NCT03872024
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03872024 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Performances Evaluation of New FibroScan Probes Dedicated to Morbidly Obese Patients - NEO Study
Lead sponsor
Echosens
Phase
Not applicable
Overall status
Completed
Start date
September 19, 2019
Completion date
March 24, 2022
Enrollment
180 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver fibrosis, obesity, morbid